Evidence map›Paper›PMID 30305069›Full record

ArticleBMC medical education2018

The Next Generation Scientist program: capacity-building for future scientific leaders in low- and middle-income countries.

Goonaseelan Pillai, Kelly Chibale, Edwin C Constable, Akiko N Keller, Marcelo M Gutierrez, Fareed Mirza, Christian Sengstag, Collen Masimirembwa, Paolo Denti, Gary Maartens and 10 more

Abstract read
In one paragraph

Article in BMC medical education, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Periodontal diseases in Africa.Periodontology 2000 · 2025
    Review
  5. Review
  6. Article
  7. Article
  8. Empowering sickle cell disease care: the rise ofFrontiers in rehabilitation sciences · 2024
    Article
  9. Article
  10. Observational
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Goonaseelan PillaiCP+ Associates GmbH, Basel, Switzerland.ORCID http://orcid.org/0000-0002-5658-3837
Kelly ChibaleDrug Discovery and Development Centre (H3D), South African Medical Research Council Drug Discovery and Development Research Unit and Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa.
Edwin C ConstableUniversity of Basel, Basel, Switzerland.
Akiko N KellerNovartis, Basel, Switzerland. akiko.keller@novartis.com.
Marcelo M GutierrezNovartis, Basel, Switzerland.
Fareed MirzaNovartis, Basel, Switzerland.
Christian SengstagUniversity of Basel, Basel, Switzerland.
Collen MasimirembwaAfrican Institute of Biomedical Science & Technology, Harare, Zimbabwe.
Paolo DentiDivision of Clinical Pharmacology, Department of Medicine, University of Cape Town, Cape Town, South Africa.
Gary MaartensDivision of Clinical Pharmacology, Department of Medicine, University of Cape Town, Cape Town, South Africa.
Michèle RamsaySydney Brenner Institute for Molecular Bioscience and Division of Human Genetics, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Bernhards OgutuUniversity of Strathmore and Kenya Medical Research Institute, Nairobi, Kenya.
Eyasu MakonnenCenter For Innovative Drug Development and Therapeutic Trials for Africa, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia.
Richard GordonMedical Research Council, Cape Town, South Africa.
Carlos Gil FerreiraD'or Institute for Research and Education, Rio de Janeiro, Brazil.
Fernando Alberto GoldbaumLeloir Institute Foundation, Buenos Aires, Argentina.
Wim M S DegraveOswaldo Cruz Institute, Fiocruz, Rio de Janeiro, Brazil.
Jonathan SpectorNovartis, Cambridge, USA.
Brigitta TadmorNovartis, Cambridge, USA.
Hedwig J KaiserUniversity of Basel, Basel, Switzerland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundScientific and professional development opportunities for early career scientists in low- and middle- income countries (LMICs) are limited and not consistent. There is a disproportionately low number of biomedical and clinical researchers in LMIC's relative to their high burden of disease, a disparity that is aggravated by emigration of up to 70% of scientists from their countries of birth for education and employment elsewhere. To help address this need, a novel University-accredited, immersive fellowship program was established by a large public-academic-private network. We sought to describe the program and summarize progress and lessons learned over its first 7-years.

methodsHallmarks of the program are a structured learning curriculum and bespoke research activities tailored to the needs of each fellow. Research projects expose the scientists to state-of-the-art methodologies and leading experts in their fields while also ensuring that learnings are implementable within their home infrastructure. Fellows run seminars on drug discovery and development that reinforce themes of scientific leadership and teamwork together with practical modules on addressing healthcare challenges within their local systems. Industry mentors achieve mutual learning to better understand healthcare needs in traditionally underserved settings. We evaluated the impact of the program through an online survey of participants and by assessing research output.

resultsMore than 140 scientists and clinicians from 25 countries participated over the 7-year period. Evaluation revealed strong evidence of knowledge and skills transfer, and beneficial self-reported impact on fellow's research output and career trajectories. Examples of program impact included completion of post-graduate qualifications; establishment and implementation of good laboratory- and clinical- practice mechanisms; and becoming lead investigators in local programs. There was a high retention of fellows in their home countries (> 75%) and an enduring professional network among the fellows and their mentors.

conclusionsOur experience demonstrates an example for how multi-sectoral partners can contribute to scientific and professional development of researchers in LMICs and supports the idea that capacity-building efforts should be tailored to the specific needs of beneficiaries to be maximally effective. Lessons learned may be applied to the design and conduct of other programs to strengthen science ecosystems in LMICs.

Indexed as

Capacity BuildingCurriculumDeveloping CountriesFellowships and ScholarshipsFemaleHumansLeadershipLearningMaleMentorsResearch PersonnelCapability developmentCapacity developmentEarly career researcher developmentEducationFellowshipPostgraduate researchPublic healthResearch and Development

Identifiers

PMID30305069
PMCPMC6180641

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.